158 related articles for article (PubMed ID: 32473073)
1. Invasive Lactococcus lactis producing mycobacterial Hsp65 ameliorates intestinal inflammation in acute TNBS-induced colitis in mice by increasing the levels of the cytokine IL-10 and secretory IgA.
da Cunha VP; Preisser TM; Santana MP; Machado DCC; Pereira VB; Miyoshi A
J Appl Microbiol; 2020 Nov; 129(5):1389-1401. PubMed ID: 32473073
[TBL] [Abstract][Full Text] [Related]
2. Mycobacterial Hsp65 antigen delivered by invasive Lactococcus lactis reduces intestinal inflammation and fibrosis in TNBS-induced chronic colitis model.
da Cunha VP; Preisser TM; Santana MP; Machado DCC; Pereira VB; Miyoshi A
Sci Rep; 2020 Nov; 10(1):20123. PubMed ID: 33208841
[TBL] [Abstract][Full Text] [Related]
3. Lactococcus lactis carrying the pValac DNA expression vector coding for IL-10 reduces inflammation in a murine model of experimental colitis.
Zurita-Turk M; Del Carmen S; Santos AC; Pereira VB; Cara DC; Leclercq SY; de LeBlanc Ad; Azevedo V; Chatel JM; LeBlanc JG; Miyoshi A
BMC Biotechnol; 2014 Aug; 14():73. PubMed ID: 25106058
[TBL] [Abstract][Full Text] [Related]
4. Lactococcus lactis carrying the pValac eukaryotic expression vector coding for IL-4 reduces chemically-induced intestinal inflammation by increasing the levels of IL-10-producing regulatory cells.
Souza BM; Preisser TM; Pereira VB; Zurita-Turk M; de Castro CP; da Cunha VP; de Oliveira RP; Gomes-Santos AC; de Faria AM; Machado DC; Chatel JM; Azevedo VA; Langella P; Miyoshi A
Microb Cell Fact; 2016 Aug; 15(1):150. PubMed ID: 27576902
[TBL] [Abstract][Full Text] [Related]
5. Oral Tolerance Induced by Heat Shock Protein 65-Producing
Guerra PV; Andrade CM; Nunes IV; Gama BC; Tibúrcio R; Santos WLC; Azevedo VA; Tavares NM; Rebouças JS; Maiolii TU; Faria AMC; Brodskyn CI
Front Immunol; 2021; 12():647987. PubMed ID: 34248935
[TBL] [Abstract][Full Text] [Related]
6. Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein.
Foligne B; Dessein R; Marceau M; Poiret S; Chamaillard M; Pot B; Simonet M; Daniel C
Gastroenterology; 2007 Sep; 133(3):862-74. PubMed ID: 17678918
[TBL] [Abstract][Full Text] [Related]
7. Recombinant
Preisser TM; da Cunha VP; Santana MP; Pereira VB; Cara DC; Souza BM; Miyoshi A
J Diabetes Res; 2021; 2021():6697319. PubMed ID: 33604389
[TBL] [Abstract][Full Text] [Related]
8. Hsp65-Producing
Gusmao-Silva G; Aguiar SLF; Miranda MCG; Guimarães MA; Alves JL; Vieira AT; Cara DC; Miyoshi A; Azevedo VA; Oliveira RP; Faria AMC
Front Immunol; 2020; 11():562905. PubMed ID: 33072101
[TBL] [Abstract][Full Text] [Related]
9. Hsp65-producing Lactococcus lactis prevents experimental autoimmune encephalomyelitis in mice by inducing CD4+LAP+ regulatory T cells.
Rezende RM; Oliveira RP; Medeiros SR; Gomes-Santos AC; Alves AC; Loli FG; Guimarães MA; Amaral SS; da Cunha AP; Weiner HL; Azevedo V; Miyoshi A; Faria AM
J Autoimmun; 2013 Feb; 40():45-57. PubMed ID: 22939403
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of intestinal inflammation in IL-10 deficient mice by a plasmid carrying Lactococcus lactis strain.
Zurita-Turk M; Mendes Souza B; Prósperi de Castro C; Bastos Pereira V; Pecini da Cunha V; Melo Preisser T; Caetano de Faria AM; Carmona Cara Machado D; Miyoshi A
BMC Biotechnol; 2020 Jul; 20(1):38. PubMed ID: 32703192
[TBL] [Abstract][Full Text] [Related]
11. Oral administration of Lactococcus lactis delivered heat shock protein 65 attenuates atherosclerosis in low-density lipoprotein receptor-deficient mice.
Jing H; Yong L; Haiyan L; Yanjun M; Yun X; Yu Z; Taiming L; Rongyue C; Liang J; Jie W; Li Z; Jingjing L
Vaccine; 2011 May; 29(24):4102-9. PubMed ID: 21497632
[TBL] [Abstract][Full Text] [Related]
12. Oral administration of recombinant Lactococcus lactis expressing HSP65 and tandemly repeated P277 reduces the incidence of type I diabetes in non-obese diabetic mice.
Ma Y; Liu J; Hou J; Dong Y; Lu Y; Jin L; Cao R; Li T; Wu J
PLoS One; 2014; 9(8):e105701. PubMed ID: 25157497
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo characterization of DNA delivery using recombinant Lactococcus lactis expressing a mutated form of L. monocytogenes Internalin A.
de Azevedo M; Karczewski J; Lefévre F; Azevedo V; Miyoshi A; Wells JM; Langella P; Chatel JM
BMC Microbiol; 2012 Dec; 12():299. PubMed ID: 23253484
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the anti-inflammatory effect of milk fermented by a strain of IL-10-producing Lactococcus lactis using a murine model of Crohn's disease.
del Carmen S; de Moreno de LeBlanc A; Perdigon G; Bastos Pereira V; Miyoshi A; Azevedo V; LeBlanc JG
J Mol Microbiol Biotechnol; 2011; 21(3-4):138-46. PubMed ID: 22286041
[TBL] [Abstract][Full Text] [Related]
15. Lactococcus lactis expressing either Staphylococcus aureus fibronectin-binding protein A or Listeria monocytogenes internalin A can efficiently internalize and deliver DNA in human epithelial cells.
Innocentin S; Guimarães V; Miyoshi A; Azevedo V; Langella P; Chatel JM; Lefèvre F
Appl Environ Microbiol; 2009 Jul; 75(14):4870-8. PubMed ID: 19482952
[TBL] [Abstract][Full Text] [Related]
16. Development of a new DNA vaccine based on mycobacterial ESAT-6 antigen delivered by recombinant invasive Lactococcus lactis FnBPA+.
Pereira VB; Saraiva TD; Souza BM; Zurita-Turk M; Azevedo MS; De Castro CP; Mancha-Agresti P; Dos Santos JS; Santos AC; Faria AM; Leclercq S; Azevedo V; Miyoshi A
Appl Microbiol Biotechnol; 2015 Feb; 99(4):1817-26. PubMed ID: 25503506
[TBL] [Abstract][Full Text] [Related]
17. Oral delivery of Lactococcus lactis that secretes bioactive heme oxygenase-1 alleviates development of acute colitis in mice.
Shigemori S; Watanabe T; Kudoh K; Ihara M; Nigar S; Yamamoto Y; Suda Y; Sato T; Kitazawa H; Shimosato T
Microb Cell Fact; 2015 Nov; 14():189. PubMed ID: 26608030
[TBL] [Abstract][Full Text] [Related]
18. Peyer's Patches as a Portal for DNA Delivery by Lactococcus lactis in Vivo.
Yano A; Takahashi K; Mori Y; Watanabe S; Hanamura Y; Sugiyama T; Inoue N
Biol Pharm Bull; 2018; 41(2):190-197. PubMed ID: 29386479
[TBL] [Abstract][Full Text] [Related]
19. Serine protease inhibitors protect better than IL-10 and TGF-β anti-inflammatory cytokines against mouse colitis when delivered by recombinant lactococci.
Bermúdez-Humarán LG; Motta JP; Aubry C; Kharrat P; Rous-Martin L; Sallenave JM; Deraison C; Vergnolle N; Langella P
Microb Cell Fact; 2015 Feb; 14():26. PubMed ID: 25889561
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of lactococci strains delivering either IL-10 protein or cDNA in a TNBS-induced chronic colitis model.
del Carmen S; Martín Rosique R; Saraiva T; Zurita-Turk M; Miyoshi A; Azevedo V; de Moreno de LeBlanc A; Langella P; Bermúdez-Humarán LG; LeBlanc JG
J Clin Gastroenterol; 2014; 48 Suppl 1():S12-7. PubMed ID: 25291117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
